MEA Technetium-99m Market to Witness Increasing Revenue Growth During the Forecast Period 2020–2027
Over the years, investments in the production of molybdenum-99 have increased significantly. Molybdenum-99 decays by emitting a beta particle and when around 88% of it decayed, it produces technetium-99m. As a result of this, key players are focused on scaling the production Mo-99. Thus, such factors can potentially augment growth of the MEA technetium-99m market in the near future. Recently, in January 2021, NorthStar Medical Radioisotopes LLC received the U.S. Food and Drug Administration (FDA) approval for the process molybdenum-99 from concentrated Mo-98 and related software upgrades for its RadioGenix System technetium-99m (Tc-99m) generator. The first step in using this particular type of mineral is to generate a high-quality Molybdenum 99m generator. This generator must contain at least six milligrams of technetium-99m. The highest quality generators can be found online and through reputable medical supply companies. Technetium-99m finds diverse applications, typically as a med...